Centaurus Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,203
Closed -$517K 655
2019
Q3
$517K Sell
5,203
-30
-0.6% -$2.85K 0.08% 258
2019
Q2
$484K Sell
5,233
-2,000
-28% -$190K 0.08% 271
2019
Q1
$682K Buy
7,233
+5,233
+262% +$458K 0.12% 208
2018
Q4
$129K Sell
2,000
-2,000
-50% -$148K 0.03% 421
2018
Q3
$391K Sell
4,000
-3,203
-44% -$283K 0.07% 274
2018
Q2
$572K Buy
7,203
+4,985
+225% +$414K 0.08% 272
2018
Q1
$198K Sell
2,218
-6,492
-75% -$623K 0.05% 329
2017
Q4
$909K Buy
+8,710
New +$983K 0.24% 111

Other funds holding CELG

Centaurus Financial's CELG Position: Q4 2019 in Review

Centaurus Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,203 shares — an estimated $517K sold.

Centaurus Financial first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $909K in Q4 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Centaurus Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Centaurus Financial sold 5,203 Celgene Corp shares in Q4 2019, an estimated $517K.
  • Centaurus Financial first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Centaurus Financial's Celgene Corp position peaked at $909K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Centaurus Financial's 13F filing for Q4 2019, filed 12 Feb 2020.